Home Search
"life science" - search results
If you're not happy with the results, please do another search
Italian venture capital and private equity industry 1999
During 1999 venture capital and private equity in Italy experienced growth and expansion. Important legal and regulatory changes introduced over the last few years are having a positive effect and here, AIFI presents the major trends and figures.
Growth of the venture capital industry in Sweden
Swedish venture capitalists may have invested over SEK11bn in 1999, but there are still factors restricting the development of the industry, according to Tom Berggren of the Swedish Venture Capital Association.
Funds: April 2001
IDG comes to Europe, Illuminator, Electra raise first funds, Penta and Atlas close, Duke Street launches new fund...
Annual European life sciences report 2001
European biotech had its best ever year in 2000, according to the eighth life sciences report from Ernst & Young. Fund raisings, valuations, revenues, employment and company IPOs all reached record levels. With recent turbulence in the high-tech sector, biotech is becoming increasingly attractive to institutional investors.
Annual European life sciences report 2000
The seventh annual European life sciences report from Ernst & Young describes the year 1999 as the ‘biotech revolution'. With many new companies springing up, advanced business models and a rush of technology, the sector has undergone a radical facelift.
The Netherlands private equity market – an overview
The Dutch private equity market has expanded over the last few years says Loyens & Loeff. However, it experienced a slump last year and by the second half of 2000 there was a surplus of funds available for investment in the Netherlands. However, it still ranked fifth in western Europe for private equity investments made.
Technology in Ireland
Since 1994, the number of technology companies in Ireland has increased by over 250 per cent. This has contributed to an increase in Irish private equity dealflow. Private equity firm Delta Partners looks at the dramatic growth of the sector, details the types of investors in the market and the routes that institutional investors can take to participate in it.
US mid-market buy-out firm Genstar Capital closes fourth fund with $475m
San Francisco-based buy-out firm Genstar Capital has closed its fourth fund with commitments totalling $475m. The firm, founded in 1988, focuses on mid-market investments in the life sciences, IT, industrial technology and business services sectors.
Popular Articles
Mercer hauls in nearly $4bn despite “challenging fundraising market”
Global consulting firm Mercer has closed the seventh vintage in its PIP strategy on over $3.9bn
Manna Tree boosts IR team with double hire following tricky Fund II raise
Health-focused PE Manna Tree has expanded its investor relations team to include Adam Whitehead and Attie Hoffman.
Carlyle among New Mexico’s $700m in commitments
The $52.7-managing New Mexico State Investment Council has pledged $700m to a string of funds, with the majority of that capital picked up by real estate vehicles.
Private equity secured a big jobs boost for Europe, latest Invest Europe survey shows
Private equity and venture capital-backed companies have continued their outsized contribution to European job number according to new data from Invest Europe.
ACORE Capital raises $1.4bn for 2024’s biggest PE real estate debt fund so far
US commercial real estate debt manager ACORE Capital has hauled in about $1.4bn for the final close of its second credit fund, the biggest raise of its type so far this year.
5th Century Partners returns to fundraising, eyes up to $250m
5th Century Partners, a mid-market investor launched by former Vistria Group and Clarion Capital Partners execs, is back in the fundraising market with its sophomore investment vehicle.
Deal Roundup: Thoma Bravo seals $5.3bn Darktrace deal, OpenGate completes SMAC exit
Thoma Bravo has agreed to pay more than $5.3bn to buy cybersecurity specialist Darktrace, at a 44% premium to its average share price over...
Norwest Ventures rakes in another $3bn fund as firm preps for succession
California-headquartered Norwest Venture Partners has closed on $3bn for its 17th flagship fund, its second vehicle in a row to collect that amount following its 2021 predecessor.
UK’s Apiary Capital beats target to close sophomore fund
London-based Apiary Capital has closed its sophomore fund above its £200m target to reach £240m.
BlackRock, Temasek haul in $1.4bn for debut Decarbonization Partners fund
Decarbonization Partners, a partnership between BlackRock and Temasek focused on companies working on the transition to a net-zero economy, has closed its debut late-stage VC fund on $1.4bn.
